Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The trial record displays its study details, including eligibility criteria, treatment plan, outcomes, and study dates. It identifies the study as terminated and no longer recruiting.
    Difference
    59%
    Check dated 2026-11-08T04:52:51.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T01:57:18.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and states that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T01:56:02.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:37:57.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:09:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the detailed study content with a generic error page. This indicates that access to the core trial information is blocked.
    Difference
    20%
    Check dated 2026-09-20T00:55:08.000Z thumbnail image

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.